Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Organovo (ONVO): I like this one, said Cramer. It's a good spec play.
St. Jude Medical (STJ): It's been quietly going up, said Cramer. It's not a fanfare stock but profits need no fanfare.
BofI Holding (BOFI): I wouldn't speculate in the bank group with this stock, said Cramer. I'd rather just buy one of the majors.
Vodafone (VOD): I think it's a great opportunity, said Cramer. What's not to like?
Express (EXPR): I can't believe how poor earnings were recently, said Cramer. I just don't understand it. They're a good company.
Nelnet (NNI): I wouldn't say 'no' to it, said Cramer, but I wouldn't say 'yes' either.
Exact Sciences (EXAS): It's a little hot, said Cramer. I'd take half off before they go before the FDA.
Sirius XM (SIRI): I think they're going to have a strong quarter, said Cramer. I like it as a long-term story.
Primerica (PRI): It's incredibly well run, said Cramer. It just goes higher and higher.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the "Mad Money" website? email@example.com